Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Cost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Arcadia Biosciences (RKDA) Tax Provisions (2016 - 2024)

Historic Tax Provisions for Arcadia Biosciences (RKDA) over the last 11 years, with Q4 2024 value amounting to $8000.0.

  • Arcadia Biosciences' Tax Provisions rose 1428.57% to $8000.0 in Q4 2024 from the same period last year, while for Dec 2024 it was $15000.0, marking a year-over-year decrease of 2857.14%. This contributed to the annual value of $8000.0 for FY2024, which is 0.0% changed from last year.
  • As of Q4 2024, Arcadia Biosciences' Tax Provisions stood at $8000.0, which was up 1428.57% from $7000.0 recorded in Q4 2023.
  • Arcadia Biosciences' Tax Provisions' 5-year high stood at $17000.0 during Q1 2020, with a 5-year trough of -$139000.0 in Q4 2020.
  • Its 5-year average for Tax Provisions is -$8272.7, with a median of $1000.0 in 2021.
  • As far as peak fluctuations go, Arcadia Biosciences' Tax Provisions crashed by 105833.33% in 2020, and later surged by 120000.0% in 2022.
  • Arcadia Biosciences' Tax Provisions (Quarter) stood at -$139000.0 in 2020, then soared by 100.72% to $1000.0 in 2021, then surged by 1200.0% to $13000.0 in 2022, then crashed by 46.15% to $7000.0 in 2023, then grew by 14.29% to $8000.0 in 2024.
  • Its Tax Provisions was $8000.0 in Q4 2024, compared to $7000.0 in Q4 2023 and $1000.0 in Q2 2023.